Full Press Release Details
Viking Therapeutics Announces Proposed Public Offering of Common Stock.
VKTX
Viking Therapeutics Announces Proposed Public Offering of Common Stock
Key Takeaway: Viking Therapeutics Announces Proposed Public Offering of Common Stock
Price reaction · baseline $38.48 (2024-02-26 close) · hit after-hours · 1 other VKTX headline(s) in the window, move may be shared
day 0 close
+121%
day 1 · peak
+145.6%
day 3
+121.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+53%
120-day peak, hindsight
Typical move
13.6%
average across 5 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
VK2735
Phase 3 · Weight Loss